Mirae Asset Global Etfs Holdings Ltd. Terns Pharmaceuticals, Inc. Transaction History
Mirae Asset Global Etfs Holdings Ltd.
- $43.9 Billion
- Q4 2024
A detailed history of Mirae Asset Global Etfs Holdings Ltd. transactions in Terns Pharmaceuticals, Inc. stock. As of the latest transaction made, Mirae Asset Global Etfs Holdings Ltd. holds 39,784 shares of TERN stock, worth $165,899. This represents 0.0% of its overall portfolio holdings.
Number of Shares
39,784
Previous 31,523
26.21%
Holding current value
$165,899
Previous $262,000
15.65%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding TERN
# of Institutions
159Shares Held
83.7MCall Options Held
473KPut Options Held
119K-
Soleus Capital Management, L.P. Greenwich, CT8.14MShares$34 Million3.16% of portfolio
-
Orbimed Advisors LLC San Diego, CA7.56MShares$31.5 Million1.14% of portfolio
-
Vivo Capital, LLC Palo Alto, CA6.9MShares$28.8 Million7.51% of portfolio
-
Deep Track Capital, LP Greenwich, CT5.58MShares$23.3 Million1.37% of portfolio
-
Schonfeld Strategic Advisors LLC New York, NY4.75MShares$19.8 Million0.17% of portfolio
About Terns Pharmaceuticals, Inc.
- Ticker TERN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 37,613,800
- Market Cap $157M
- Description
- Terns Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops small-molecule single-agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis (NASH) and obesity. The company develops TERN-101, a liver-distributed and non-bile acid farnesoid X receptor agonist, which is in Phase IIa clinical t...